Patent details

Basic Information

Publication number:

EP3860590

PCT Application Number:

US2019054576

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP197904048

PCT Publication Number:

WO2020072824

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ETRASIMOD FOR USE IN METHODS FOR THE TREATMENT OF SCLERODERMA

French Title of Invention:

ETRASIMOD POUR L'UTILISATION DANS LES MÉTHODES POUR LE TRAITMENT DE LA SKLÉRODERMIE

German Title of Invention:

ETRASIMOD ZUR VERWENDUNG IN METHODEN ZUR BEHANDLUNG VON SKLERODERMIE

SPC Number:

Dates

Filing date:

03/10/2019

Grant date:

07/06/2023

EP Publication Date:

11/08/2021

PCT Publication Date:

09/04/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2023

EP B1 Publication Date:

07/06/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2023

Expiration date:

03/10/2039

Renunciation date:

Revocation date:

02/10/2024

Annulment date:

Owner

From:

31/05/2023

 

 

Name:

Arena Pharmaceuticals, Inc.

Address:

66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

Name:

ADAMS, John W.

Address:

United States (US)

Priority

Priority Number:

201862740855 P

Priority Date:

03/10/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/404; A61P 37/00;

Publication

European Patent Bulletin

1

Issue number:

202323

Publication date:

07/06/2023

Description:

Grant (B1)

2

Issue number:

202506

Publication date:

05/02/2025

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages